New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
07:32 EDTALQAAlliqua acquires Choice Therapeutics for about $4M in stock, cash
Alliqua has acquired Choice Therapeutics, a privately held wound care company with proprietary technologies and products, for approximately $4m in stock and cash. The merger agreement, which became effective May 5, provides for additional contingent payments of up to $5M in stock or cash, under certain circumstances, if stated revenue thresholds are reached over the next three years ending April 30, 2017. The acquisition is expected to be accretive to Alliqua's earnings during the next 12 months. As part of the agreement, Alliqua has acquired Choice Therapeutics' wound care portfolio, its technology platform and its sales and marketing team.
News For ALQA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 6, 2014
07:34 EDTALQAAlliqua expands exclusive licensing agreement with Celgene
Alliqua Biomedical (ALQA) announced that the company has amended its exclusive licensing agreement with Celgene Cellular Therapeutics, or CCT, a subsidiary of Celgene (CELG). Under the terms of the amended agreement, Alliqua has received the right to market the advanced wound care product, Biovance, for podiatric and orthopedic applications. Biovance is a, decellularized, and dehydrated, human amniotic membrane allograft, which was commercially launched by Alliqua on April 23. The product is currently indicated for the management of non-infected partial- and full-thickness wounds, including chronic and acute wounds such as diabetic ulcers, pressure ulcers, venous ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, and draining wounds, The field of use for Biovance has been expanded to include podiatric and orthopedic applications including sports medicine-related conditions pertaining to use during the repair of tendon, nerve and bone in the foot and ankle, as well as other surgical procedures in these specialty areas.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use